SEC
Whistleblower
Attorneys

September 27, 2019

Mylan N.V.

Financial Fraud

SANCTION AMOUNT: $30000000

Defendants: Mylan N.V.

Pharmaceutical company agreed to settle charges of accounting and disclosure failures relating to a Department of Justice probe into whether it overcharged Medicaid by hundreds of millions of dollars for EpiPen, its largest revenue and profit generating product.

Thank you for submitting some email to us.